Literature DB >> 23601680

Dysfunctional HDL takes its toll in chronic kidney disease.

Kathryn J Moore1, Edward A Fisher.   

Abstract

Why patients with chronic kidney disease have elevated cardiovascular risk remains elusive. In this issue of Immunity, Speer et al. (2013) show that natural modification of high density lipoprotein promotes hypertension through a Toll-like receptor-dependent mechanism.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Year:  2013        PMID： 23601680     DOI： 10.1016/j.immuni.2013.03.006

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  5 in total

1.  Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study.

Authors:  Chin-Sheng Lin; Sy-Jou Chen; Chih-Chien Sung; Cheng-Li Lin; Shih-Hua Lin; Shu-Meng Cheng; I-Kuan Wang; Wen-Sheng Huang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

2.  Urinary soluble CD90 predicts renal prognosis in patients with diabetic kidney disease.

Authors:  Liang Wu; Dong-Yuan Chang; Lu-Xia Zhang; Min Chen; Ming-Hui Zhao
Journal:  Ann Transl Med       Date:  2021-02

3.  Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants.

Authors:  Ahmed Bakillah; Fasika Tedla; Isabelle Ayoub; Devon John; Allen J Norin; M Mahmood Hussain; Clinton Brown
Journal:  Mediators Inflamm       Date:  2015-11-15       Impact factor: 4.711

Review 4.  Clinical predictive factors in diabetic kidney disease progression.

Authors:  Nicholas J Radcliffe; Jas-Mine Seah; Michele Clarke; Richard J MacIsaac; George Jerums; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2016-06-08       Impact factor: 4.232

5.  Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.

Authors:  Dmitry V Burdin; Alexey A Kolobov; Chad Brocker; Alexey A Soshnev; Nikolay Samusik; Anton V Demyanov; Silke Brilloff; Natalia Jarzebska; Jens Martens-Lobenhoffer; Maren Mieth; Renke Maas; Stefan R Bornstein; Stefanie M Bode-Böger; Frank Gonzalez; Norbert Weiss; Roman N Rodionov
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.